Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study — Stella

Home/Metabolic Dysfunction-associated Fatty Liver Disease/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Dysfunction-associated Fatty Liver Disease trials

Trial locations(1 site)

China

The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality

Key details

Sponsor

Chongqing Medical University

Enrollment target

~7,000 participants

Started

July 2023

Primary completion

December 2026

Age range

18 Years – 90 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.